gMG race hots up as AstraZeneca’s star candidate meets Phase III targets
The pharmaceutical giant is now likely to apply for gefurulimab’s approval with the FDA.
25 July 2025
25 July 2025
The pharmaceutical giant is now likely to apply for gefurulimab’s approval with the FDA.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.